Exploring the Relationship Between Immune Cells and Non-Scarring Hair Loss: A Mendelian Randomization Study
Hongtao Liu,Xiao Huang,Hongji Wei,Yanchang Nong
DOI: https://doi.org/10.2147/ccid.s467185
2024-07-06
Clinical Cosmetic and Investigational Dermatology
Abstract:Hongtao Liu, Xiao Huang, Hongji Wei, Yanchang Nong Clinical Medical School, Guangxi Health Science College, Nanning, People's Republic of China Correspondence: Yanchang Nong, Clinical Medical School, Guangxi Health Science College, Nanning, People's Republic of China, Email Background: Non-scarring hair loss (NSHL) is a global health concern with increasing prevalence due to lifestyle changes and an aging population. It can cause psychological distress and affect quality of life. Objective: This study aimed to identify the associations between NSHL and immune cell phenotypes using a two-sample Mendelian randomization (MR) analysis, offering insights for future immune-based therapies for NSHL. Methods: We obtained immunocyte data from the IEU Open GWAS Project and NSHL data from the same database and used MR analysis to evaluate the causal association between each immunophenotype and NSHL. Three statistical methods were employed: the MR-Egger regression, weighted median estimation, and inverse variance weighting (IVW). Results: The MR resonance imaging identified 31 immunocyte phenotypes associated with NSHL. Among these, 19 immunocyte phenotypes were negatively associated with NSHL, indicating their protective effects. The remaining 12 immunocyte phenotypes were positive association. Sensitivity analyses suggested the robustness of all MR findings. Conclusion: These findings highlight a clear correlation between NSHL and immunity, demonstrating the significant role of certain immune cell phenotypes. This study offers a new direction for immune-based therapies in the treatment of NSHL. Keywords: non-scarring hair loss, immune cell, Mendelian randomization, immunotherapy Hair loss (HL) is a global issue and its prevalence continues to increase with human lifespan and lifestyle changes. 1 In particular, non-scarring hair loss (NSHL) causes great distress and has an adverse psychological impact on many individuals. 2 Currently, the main methods for treating NSHL are medications, such as minoxidil and finasteride, and surgical interventions, such as hair transplantation. However, these methods have potential side effects, including rashes, headaches, and sexual dysfunction. 3,4 In addition to genetic factors, changes in human lifestyle are believed to be among the main contributors to the increased prevalence of hair loss. Factors, such as poor dietary habits, lack of exercise, and significant psychological stress, are associated with hair loss. Furthermore, on a global scale, environmental factors, such as air pollution and exposure to ultraviolet radiation, have been found to be closely correlated with the incidence of hair loss. 5,6 Understanding the etiology and mechanisms of illness is crucial for disease treatment. Changes in lifestyle habits and stress can lead to alterations in human immune function. 7,8 Studies are currently examining the relationship between hair loss and the immune system. 9,10 This provides a new direction for the future implementation of immunotherapy for the treatment of NSHL. However, a key prerequisite for successful immunotherapy is the identification of immune cells associated with NSHL. Mendelian randomization (MR) is a methodology used to assess causality in observational studies. This method is based on Mendelian inheritance principles, which suggest that the inheritance of genetic variation occurs randomly. Consequently, the genetic variations associated with specific diseases may have influenced the variables under consideration. The MR investigates the correlation between exposure and outcomes by contrasting populations with distinct genetic variations. This approach provides superior control over potential confounding factors compared with conventional observational studies, thereby enhancing the reliability of the conclusions. 11 Therefore, our study aimed to examine the association between NSHL and immune cells using two-sample MR analysis. We acquired immunocyte data from the Ieu Open Gwas Project ( http://gwas.mrcieu.ac.uk ), a genome-wide association studies database. 12 These data were used as exposure data in this study. The identification numbers for the data ranged from GCST0001391 to GCST0002121. In this study, we conducted a genome-wide association analysis of 629 blood immune cell-related traits in 272,100 individuals from the European general population. The study included 731 immunophenotypes. 13 We obtained the NSHL data[ID: finn-b-L12_HAIRLOSSNONSCAR, Year:2021, Population: European, Sex: Males and Females, n(case):81, n (control): 211,139, Number of SNPs: 16,380,450] as the outcome using the same method. Following data acquisition, we conducted separate -Abstract Truncated-
dermatology